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Handling incomplete correlated
continuous and binary outcomes in
meta-analysis of individual
participant data
Manuel Gomes,a*† Laura Hatfieldb and Sharon-Lise Normandc
Meta-analysis of individual participant data (IPD) is increasingly utilised to improve the estimation of treatment
effects, particularly among different participant subgroups. An important concern in IPD meta-analysis relates
to partially or completely missing outcomes for some studies, a problem exacerbated when interest is on multi-
ple discrete and continuous outcomes. When leveraging information from incomplete correlated outcomes across
studies, the fully observed outcomes may provide important information about the incompleteness of the other
outcomes. In this paper, we compare twomodels for handling incomplete continuous and binary outcomes in IPD
meta-analysis: a joint hierarchical model and a sequence of full conditional mixedmodels.We illustrate how these
approaches incorporate the correlation across the multiple outcomes and the between-study heterogeneity when
addressing the missing data. Simulations characterise the performance of the methods across a range of scenar-
ios which differ according to the proportion and type of missingness, strength of correlation between outcomes
and the number of studies. The joint model provided confidence interval coverage consistently closer to nominal
levels and lower mean squared error compared with the fully conditional approach across the scenarios consid-
ered. Methods are illustrated in a meta-analysis of randomised controlled trials comparing the effectiveness of
implantable cardioverter-defibrillator devices alone to implantable cardioverter-defibrillator combined with car-
diac resynchronisation therapy for treating patients with chronic heart failure. © 2016 The Authors. Statistics in
Medicine Published by John Wiley & Sons Ltd.
Keywords: joint modelling; Bayesian analysis; fully conditional specification; multiple imputation; missing
data; IPD meta-analysis
1. Introduction
Patient-centered outcomes research seeks, among other things, to understand which patients are most
likely to benefit from available treatments, yet randomised controlled trials of new therapies are designed
to answer primary efficacy questions, and often lack power to detect differential treatment effects across
patient subgroups. Meta-analysis of individual participant data (IPD) can aid the estimation of subgroup
treatment effects by pooling information from multiple studies and using patient-level data to improve
precision. An important concern when pooling data across studies relates to partially or completely
missing data for some studies. The main problem with missing data is that individuals with incomplete
information tend to be systematically different from those with complete data, and inferences based on
the complete cases may be misleading. Recent studies considered methods for handling predictors or
confounders that are missing for some studies [1, 2]. In this paper, we consider the dual problem of out-
comes that are partially or completely missing for some studies, and multiple outcomes measured per
study participant.
The approach taken to handling missing data should carefully consider the reasons that give rise to
missing outcomes [3]. Most published IPD meta-analyses simply discard the observations with missing
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data in each individual study and report complete case analysis (CCA) [4]. This ‘unprincipled’ approach
assumes that the data are missing completely at random (MCAR); that is, missing values are indepen-
dent of any observed or unobserved factors or may depend on variables included in the analysis model
but are independent of other observed values (for example, other covariates or outcomes), a mecha-
nism also known as covariate-dependent missing completely at random (CD-MCAR) [3]. If patients with
missing outcomes differ from those with complete information according to observed or unobserved
characteristics (not adjusted in the analysis model), CCA will lead to inaccurate treatment effects. Prin-
cipled approaches for handling missing data, such as multiple imputation (MI), maximum likelihood
approaches, and full-Bayesian analysis typically assume that data are missing at random (MAR). That is,
the probability of missing data is independent of any unobserved values given the observed data. If the
probability of missing data is associated with unobserved values, then the data are said to be missing not
at random (MNAR).
The presence of multiple outcomes in randomised controlled trials is the norm rather than the exception
[5]. The assessment of alternative healthcare interventions is often based on multiple endpoints in order
to characterise effects on a broad set of domains. For example, in medical devices studies, both patients
and providers care about functional outcomes such as limits on daily activities, clinical endpoints such
as time to progression or death, and device outcomes such as battery life and wear [6,7]. The multiplicity
of outcomes has implications for the choice of statistical method for addressing the missing data. First,
outcomes may be correlated within an individual participant; for example, patients with worse clinical
endpointsmay also have poorer functional outcomes.With incomplete correlated outcomes, the interest in
addressing the missing data is greater compared with a single missing outcome as this allows us to appro-
priately handle the correlation between outcomes. Modelling correlated outcomes jointly can improve
precision of treatment effects when compared with analysing them separately and enables joint infer-
ences [8]. In the context of IPD meta-analysis, it is important to recognise that the relationships among
multiple outcomes may arise at both the patient and the study level. Second, the probability that one
outcome is observed (e.g. self-reported quality-of-life) may depend, not only on patient and study-level
characteristics, but also on the other outcomes (e.g. clinical status). Third, population mean outcomes
and associated variances, as well as prognostic relationships including treatment effects, typically differ
across studies. Methods should appropriately address the between-study heterogeneity when addressing
the missing data. Fourth, differences in study design may cause some outcomes to be completely (or sys-
tematically) missing in some studies. In this case, leveraging information from the remaining studies to
compensate for studies with systematically missing outcomes may be useful for inferences.
Our work is motivated by a meta-analysis of randomised controlled trials that compare implantable
cardioverter-defibrillator (ICD) devices alone to ICD combined with cardiac resynchronisation therapy
(CRT-D). A few clinical factors are known to moderate the effectiveness of these devices, and recent
investigations have focused on the question of whether men and women respond differently to these
treatment options. Previous clinical trials have shown that these devices can improve survival, function
and quality of life in patients with heart failure [9,10]. However, most of the US clinical trials that gener-
ated the evidence leading to device approval enrolled small numbers of women and each trial had its own
restrictive entry criteria, which limited the ability to study broad sex heterogeneity in any individual trial.
In this paper, we consider twomodels for handling incomplete correlatedmixed outcomes in IPDmeta-
analysis: a joint hierarchical model [11] and a sequence of full conditional mixed models [12, 13]. The
way the joint model and the full conditional approach accommodate the correlation across outcomes and
the between-study heterogeneity when dealing with the missing data is distinct. The joint hierarchical
model can incorporate the correlation structure among continuous and binary outcomes at both individ-
ual and study levels. Alternatively, specifying a sequence of univariate hierarchical regressions for each
outcome conditional on all others avoids the complexity of specifying a joint hierarchical model, but the
correlation between outcomes is not explicitly partitioned into patient and study-level components.
Both the joint and full conditional models can be used with MI for handling the missing data [14].
With MI, each missing value is replaced by a set of plausible values drawn from the posterior distribution
of the missing data given the observed. MI allows the model for the missing data (imputation model) to
be specified separately from the model for the complete data (substantive model). This paper considers
MI to estimate the full conditional models using the chained equations approach, where the incomplete
outcomes are imputed one at a time conditional on the observed data [15]. For the joint model, we use a
full-Bayesian approach because current software options to implement MI to jointly impute continuous
and binary hierarchical outcomes are limited. In the Bayesian framework, the missing values are simply
nuisance parameters estimated along with the other unknowns (single step), ensuring internal consis-
tency. Differences between MI and full-Bayesian analysis for estimating the joint model (with missing
outcomes) are trivial [16].
© 2016 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd. Statist. Med. 2016, 35 3676–3689
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In non-hierarchical settings, previous work has shown that imputing the missing outcomes iteratively
is asymptotically equivalent to specifying a full joint distribution [13,17,30]. That is, the imputed values
from the chained equations converge to the values drawn from the posterior distribution implied by the
joint model. However, it is unclear whether this equivalence holds in hierarchical settings such as meta-
analysis of patient-level data. Hughes and colleagues [18] provide a condition – non-informative margins
– which together with compatibility [17], is sufficient for full conditional and joint models to produce
values from the same predictive distribution. This condition requires that the marginal distribution of the
conditioning variables provide no information about the parameters of the missing variable’s imputation
distribution. Specifying full conditional models of continuous and binary hierarchical variables that sat-
isfy this condition is challenging [14, p 221].With the joint model, all outcomes are included as responses,
and it requires specifying an adequate covariance structure. Under this approach, the covariance of the
incomplete variables is partitioned into individual and study-level components, allowing for potentially
complex correlation structures between outcomes [19]. This paper investigates whether the joint hierar-
chical model yields more accurate treatment effect estimates compared with the full conditional approach
in IPD meta-analysis.
We assess the performance of the joint hierarchical model and a sequence of full conditional mixed
models, across different circumstances in IPD meta-analysis of correlated continuous and binary out-
comes.We find that both approaches perform relatively well across all scenarios, although the joint model
yields confidence interval (CI) coverage consistently closer to nominal levels and lower mean squared
error, particularly when the outcomes are strongly correlated. Estimates of the average treatment effects
of ICD versus CRT-D for men and women are similar according to method, but the joint model pro-
vides more precise estimates. In the next section, we describe how each model addresses the correlation
across the multiple outcomes and the between-study heterogeneity when addressing the missing data. In
Section 3, we describe our meta-analysis of randomised controlled trials comparing implantable cardiac
devices to treat heart failure, with missing binary and continuous outcomes (mortality, functional and
quality-of-life endpoints). Section 4 outlines the simulation study. Sections 5 and 6 report the results of
the simulations and case study. Finally, Section 7 discusses the findings and proposes some avenues for
further research.
2. Methods
2.1. Joint hierarchical model
In this paper, we consider joint hierarchical models for a mixture of continuous and binary responses;
extension to ordinal and categorical outcomes is relatively straightforward [11]. When all incomplete
outcomes are continuous, a multivariate normal model is the obvious choice. When incomplete outcomes
are a mixture of continuous and binary, we can use a latent normal variable for each discrete outcome,
and then model these jointly with the continuous outcomes using the multivariate normal model [20].
Let Y1,ij and Y2,ij be a continuous and binary outcome, respectively, for individual i in study j. Let Zij
be a latent variable underlying Y2,ij, where Y2,ij = 1 when Zij is positive, 0 otherwise. In addition, let Xij
be the set of predictors of the missing data. The unknown parameter of interest is the average effect of
a treatment defined by tij, where tij = 1 if the ith patient in study j is assigned to the new treatment, 0
otherwise. Then, we write our latent normal joint hierarchical model as
Y1,ij = 𝜇1,ij + e1,ij
Zij = 𝜇2,ij + e2,ij P(Y2,ij = 1) = P
(
Zij > 0
)(
e1,ij
e2,ij
)
∼ N
[
0,𝛀e =
(
𝜎21 𝜌𝜎1𝜎2
𝜎22
)]
and
(
u1,j
u2,j
)
∼ N
[
0,𝛀u =
(
𝜏21 𝜙𝜏1𝜏2
𝜏22
)] (1)
where 𝜇k,ij = 𝛽k,0 + 𝛽k,1tij + 𝛽k,2Xij + uk,j for k = 1, 2. The covariance matrices 𝛀e and 𝛀u govern
the individual and study-level variability, respectively. For identification, the variance of the discrete
outcome, 𝜎22 , is fixed to 1. The correlation between responses at the individual and study-level is explicitly
recognised via the parameters 𝜌 and 𝜙, respectively. Model (1) assumes that only the random intercepts
(u1,j, u2,j) vary across studies. Models that include heterogeneous treatment effects are considered later
in this paper.
The joint model is estimated using a full-Bayesian approach. With Bayesian analysis, we need a joint
likelihood for the complete data, P(Y|X, 𝜃), and a prior distribution for the unknown parameters, P(𝜃),
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including the treatment effect. Conditional on the observed outcomes, Yobs, the posterior distribution is
defined as P(𝜃|X,Yobs). While full-Bayesian analysis can allow additional information to enter via the
prior distributions, we do not exploit this feature here, and instead considered vague or weakly informative
priors throughout [21, 22]. Because the focus of the paper is on incomplete outcomes, we do not need a
separate missingness model for the missing values, Ymis, provided that data are MAR. For this to hold, X
in model (1) must include all variables that predict the missing values and the probability of missingness.
Details about a Markov Chain Monte Carlo algorithm to estimate the parameters of interest are provided
in Supporting Information, Appendix A.
2.2. Fully conditional specification
Under the fully conditional specification (FCS), the multivariate model is specified by a series of condi-
tional models, one for each incomplete outcome. Using the same continuous and binary outcomes earlier
(Y1,ij, Y2,ij), we define our two full conditional models as
Y1,ij|Y2,ij ∼ N (𝜇1,ij + 𝛼1Y2,ij, 𝜎21)
Y2,ij|Y1,ij ∼ Ber
{
exp
(
𝜇2,ij + 𝛼2Y1,ij
)
1 + exp
(
𝜇2,ij + 𝛼2Y1,ij
)} (2)
where 𝜇1,ij and 𝜇2,ij are defined previously. Model (2) allows for the between-study heterogeneity by
including study-specific random intercepts (uk,j). The parameters governing the relationships between the
two outcomes are 𝛼1 and 𝛼2.
Multiple imputation by chained equations [15] is an attractive approach for addressing missing data
under the fully conditional approach. With MI, each missing value is replaced with a set of M plausible
values. These values are drawn, in a Bayesian manner, from the conditional distribution of the missing
observations given the observed data so that the set of imputed values reflects the uncertainty associated
with both the missing data and the estimation of the parameters in the imputation model. Hence, MI is
regarded as an approximate Bayesian method. A distinct feature of MI compared with the full-Bayesian
analysis is that the model for the missing values is specified separately from the substantive model for
estimating the parameters of interest.
After constructing M multiple imputed data sets, we apply the following substantive model to each
dataset:
Y1,ij = 𝛽1,0 + 𝛽1,1tij + 𝛽1,2Xij + u1,j + e1,ij
probit(Y2,ij = 1) = 𝛽2,0 + 𝛽2,1tij + 𝛽2,2Xij + u2,j + e2,ij
eij ∼ N(0,𝛀e) uj ∼ N(0,𝛀u) .
(3)
The parameters of interest such as the treatment effects 𝛽1,1 and 𝛽2,1 are combined using Rubin’s rules
[3], to properly reflect the variation both within and between imputations.
The chained equations algorithm to generate M imputed datasets is described in Supporting Informa-
tion, Appendix B. Unlike the joint model, each incomplete outcome is imputed at a time, conditional
on all other variables in the imputation model (including the other outcomes). It is unclear whether the
stationary distribution generated by this fully conditional approach based on Model (2) asymptotically
approximates the posterior predictive distribution implied by the joint hierarchical Model (1). Our simu-
lation study assesses the relative performance of these alternative approaches to handle the missing data
when estimating treatment effects in IPD meta-analysis.
2.3. Complete case analysis
A relatively simple approach to missing data is to apply the substantive model (3) to the complete data,
discarding patients for whom at least one outcome is missing. This approachmakes the strong assumption
that missingness is unrelated to unobserved values, conditional on the variables included in the substan-
tive model. However, patients with incomplete data may differ from those with complete information
according to other observed or unobserved characteristics, and inferences based on the complete cases
may be biased. In addition, CCA can lead to large proportions of patients being dropped, or some stud-
ies being discarded altogether (in the case of systematically missing outcomes). For completeness, we
consider CCA as a worst-case alternative prone to both bias and inefficiency.
© 2016 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd. Statist. Med. 2016, 35 3676–3689
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3. Motivating example
Our motivating data come from five randomised controlled trials of implantable cardiac devices used to
treat heart failure obtained from the Center for Devices and Radiological Health, the United States Food
and Drug Administration. ICD devices can sense abnormal heart rhythms and deliver a high-voltage
shock to correct an arrhythmia in order to prevent cardiac arrest and sudden death. These devices are often
combined with additional pacing leads for patients who also require regular pacing. For some patients,
this means bi-ventricular pacing or cardiac resynchronisation therapy (CRT). We combined data from
studies that compared an ICD alone to ICD with CRT function added (CRT-D).
Wewant to compare treatment effects onmultiple outcomes, not just a single endpoint. These comprise
mortality, improvement in physician-rated disease severity on the New York Heart Association (NYHA)
scale (1 if NYHA class improved, 0 otherwise), a functional measure of the distance walked in 6 min,
and quality-of-life measured by the Minnesota Living with Heart Failure questionnaire. In particular, we
would like to investigate whether men and women respond differently to treatment. Combining data from
across studies enlarges the sample size, allowingmore precise subgroup treatment effect estimates. This is
particularly true in these trials, which enrolled small numbers of women. Each individual study specified
different times at which functional and quality-of-life outcomes were measured. Here, we considered
1-year endpoints whenever available (three studies), and 6-month otherwise (two studies).
New York Heart Association, 6-min walk and quality of life outcomes are not defined for patients
who die before the time designated for their outcomes to be measured. An approach commonly used in
longitudinal settings is to jointly model the survival time with outcomes censored due to death. In our
setting, outcomes are measured only at two time points, and these models are not feasible. Given the
low proportion of mortality (4%) and to be consistent with the trials’ primary analysis, we assumed that
when patients die they have the same outcomes measured in the previous time point. For example, if
a patient dies between 6 and 12 months, the 1-year analysis considers the outcome values measured at
6 months. As a sensitivity analysis, we set all those outcomes to their ‘worst’ values (zeros in all cases) in
the presence of mortality. In other words, we assumed that deceased patients’ quality of life is zero, the
NYHA binary outcome is zero (no improvement in NYHA class compared with baseline) and number
of metres walked in 6 min is also zero. Not surprisingly, the results are very similar to those presented in
Figure 3 given the small proportion of censored outcomes due to death.
Table I describes the main characteristics of these five studies, by intervention group. The proportion
of missing data varied across studies. While mortality was fully observed for most studies, all other
outcomes had high proportions of missing values per study ranging from 5% to 100%. Quality-of-life
as measured by the Minnesota Living with Heart Failure questionnaire was completely missing for two
studies; one study did not include this outcome in the protocol, and another used a different quality-of-
life questionnaire. The proportion of complete cases, that is, patients who had all outcomes observed was
52%. The proportion of female patients in most trials was below 20% (sex indicator was fully observed).
The range of correlations between outcomes was similar across studies and treatment arms but differed
across outcomes. For example, mortality was weakly associated with any of the other outcomes (corre-
lation coefficient ranged from 0.03 to 0.17), but the functional outcomes were more strongly correlated
between them and with quality-of-life (0.18 to 0.39). The proportion of the total variation at the study
level was relatively higher for the quality-of-life outcome (intra-study correlation coefficient of 0.14)
than the other outcomes (intra-study correlation coefficient below 0.10).
4. Simulation study
4.1. Data-generating process
The simulation study was designed to replicate typical features of IPD meta-analyses (including those
of our motivating example). Let the active treatment group be defined by tij = 1 and the control group
by tij = 0. We simulate continuous and binary variables from a joint distribution using copulas, a useful
method for constructing a joint distribution given the marginals [23]. For the ith individual in study j,
let Y1,ij ∼ N
(
𝜇1,ij, 𝜎
2
1
)
be the continuous outcome and Y2,ij ∼ Bernoulli
(
𝜋ij
)
be the binary outcome.
Drawing from a multivariate normal, converting to the uniform CDF scale, and then inverting the CDFs
of both marginals, we obtain a draw from a joint distribution. Specifically, the parameters of the two
marginals are
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𝜇ij = 1 + 1tij + 0.5X1,ij + 0.5X2,ij + u1,j
logit(𝜋ij) = −0.5 + 0.1tij + 0.2X3,ij + 0.2X4,ij + u2,j
(4)
(
u1,j
u2,j
)
∼ N
[(
0
0
)
,
(
1 𝜙
𝜙 1
)]
where Xk,ij ∼ MVN (𝟎,𝚺) for k = 1,… , 4 and𝚺 is the k×k identity matrix. Model (4) produces outcomes
that are correlated both within each individual participant (𝜌) via the copula, and within study (𝜙) via the
random effects (u1,j and u2,j). We assume a unit variance for the continuous variable, 𝜎
2
1 = 1, and chose
regression coefficients so that the correlation between covariates and outcomes was about 0.5. The true
treatment effects are 1 for the continuous outcome and 0.1 for the binary outcome. Note that the linear
predictor from a probit model (used to estimate the substantive model) is 0.6 that from the logit model
and hence the true value under the probit model is 0.06 [14, p. 94–95].
Next, we describe the framework to simulate the missing data. We considered scenarios where out-
comes are missing for some patients within each study (sporadically missing), and missing for all patients
in some studies (systematically missing). Let P(Rk,ij = 1) denotes the probability that the kth response
for individual i in study j is missing. We simulated sporadically missing outcomes under MAR as
logitP
(
Rk,ij = 1|Xk,ij,Y−k,ij) = 𝜃k,0 + 𝜃k,1Xk,ij + 𝜃k,2Y−k,ij (5)
that is, the probability of missingness may be related to observed covariates Xk,ij as well as the other
response, Y−k,ij. We chose 𝜃k,0 and 𝜃k,1 to produce correlation of about 0.3 between themissingness indica-
tor (Rk,ij) and the predictors (Xk,ij). For scenarios where the probability of observing one outcome depends
on the other outcome (𝜃k,2 ≠ 0), we have randomly split the sample in two and applied model (5) to each
sub-sample (one for each outcome k) in order to preserve MAR. This ensures that, for each sub-sample,
the P(Rk,ij = 1|Xk,ij,Y−k,ij) only depends on observed values of Y−k,ij. For systematically missing data, we
set binary outcomes to missing for all individuals in some studies.
Table II summarises the parameter values across the scenarios. We contrast scenarios with few studies
to those with more studies and thus more plausible asymptotics for the study-level random effects. We
consider alternative levels (low versus high) of correlations between outcomes at the individual (𝜌 = 0.2
and 0.7) and study-level (𝜙 = 0.1 and 0.3). We compare scenarios with proportions of missing data that
are low (20%) or high (50%), and scenarios in which missingness depends only on observed covariates or
also on the other endpoint. In addition, we considered systematically missing data for the binary outcome;
for these scenarios, we set sporadically missing values to ‘low’ (20%) for the continuous outcome and
then set the binary outcome to be completely missing in a few or many studies. The total sample size was
3000 across all scenarios, with a balanced treatment allocation between the two arms.
4.2. Implementation
For the FCS–MI approach, we conducted 10 imputations and 10 iterations between each imputation. The
overall MI procedure was implemented in R using the mice package. To impute continuous outcomes,
we used the 2l.norm.me method [1] which allows for both sporadically and systematically missing data.
Table II. Factors and their chosen levels varying across the different scenarios.
Parameter Values
Sample size (i) 20 studies, 150 individuals/study
(ii) 5 studies, 600 individuals/study
Correlation between responses Study level: (i) 𝜙 = 0.1; (ii) 𝜙 = 0.3
Individual level: (i) 𝜌 = 0.2; (ii) 𝜌 = 0.7
Missingness predictors (i) Covariates Xk,ij
(ii) Covariates Xk,ij and the other outcome Y−k,ij
% missing across studies (i) 20% and (ii) 50%
Systematically missing data set binary outcome to be completely missing
for J studies such that overall % missingness
is around (i) 20% and (ii) 50%
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Similarly, we used the 2l.bin algorithm [24] for imputing binary outcomes. We considered two fully
conditional models: one which does not include the other outcomes in the imputation model (Fully Con-
ditional 1), that is, assume 𝛼1 = 𝛼2 = 0 (Model 2); and one that includes the other outcomes (Fully
Conditional 2).We hypothesise that evenwhen the probability of one outcome beingmissing is not related
to the other outcome (𝜃k,2 = 0, model 5), including the other endpoint in the imputation model may
improve CI coverage given the correlation between the outcomes. After imputation, we applied the anal-
ysis model (3) to each multiple imputed dataset using MLwiN via interface with the R2MLwiN package
in R, which facilitates the estimation of joint multilevel models with mixture types of responses [25].
The joint hierarchical model, assuming vague priors, is described in Supporting Information,
Appendix C. We considered 50 000 Markov Chain Monte Carlo iterations, after which convergence was
good for both regression coefficients and variance/covariance parameters (Gelman–Rubin scale reduc-
tion factor was smaller than 1.1). The Bayesian approach was implemented in JAGS [26], which can be
used via interface with R rjags package. The joint hierarchical model could also be used with MI, but
joint imputation models for mixed hierarchical responses require the use of specialist software such as
Realcom-impute [27]. This stand-alone package is computationally slow, and the existing version cannot
be automatised, making it impractical for our simulation study. For each scenario, we apply the methods
to 1000 simulated datasets and compare the approaches according to bias, rootmean squared error (rMSE)
and joint CI coverage [28] for the treatment effects on continuous and binary outcomes.
5. Results
Table III shows the results for scenarios where the probability of missingness depends only on the
covariates (sporadically missing outcomes only). Across these scenarios, we varied the individual-level
correlation (but fixed study-level correlation, 𝜙 = 0.1), the proportion of missing data and the number of
studies. Both the joint model and FCS approaches provided treatment effect estimates close to the truth
and joint CI coverage near the nominal level (95%). Including the other outcome in the imputation model
(Fully Conditional 2) did not improve performance when compared with Fully Conditional 1, even when
the outcomes are highly correlated. The joint model provides slightly lower rMSE (closer to that of the
full data analysis). CCA was biased and had poor (below 0.8) CI coverage, even with little missing data,
many studies and weak correlation between outcomes.
Figures 1 and 2 show the results for scenarios with five studies where the probability of observing one
outcome depends on both the observed covariates and the other outcome. The FCS approach that does
not include the other endpoint (Fully Conditional 1) led to under-coverage (below 0.9, Figure 1). This
was anticipated because this imputation model is misspecified; it excludes the other outcome, which is
predictive of missingness. The joint model provides joint CI coverage somewhat closer to the nominal
levels than the correctly specified FCS approach (Fully Conditional 2), particularly for a higher propor-
tion of missing data and strongly correlated outcomes within each participant. When we increased the
strength of the study-level correlation across outcomes (𝜙 = 0.3), the CI coverage of Fully Conditional
2 deteriorated further, whereas that of the joint model remained close to nominal levels (Supporting
Information, Figure 1). In terms of bias, both joint model and FCS approaches performed well on the
continuous outcome treatment effect, with relative biases below 2% (Figure 2). However, the joint model
produced the lowest bias in the binary outcome treatment effect. This approach also produced lower rMSE
than the other methods (Supporting Information, Figure 2). We observed similar results when the con-
tinuous outcome is sporadically missing and the binary outcome is systematically missing (Supporting
Information, Table 2).
6. Application to cardiac resynchronisation therapy data
The parameters of interest are the subgroup treatment effects (men vs women) on four outcomes: mor-
tality and NYHA class (binary), 6-min walk and quality-of-life (continuous). We fit models with a
treatment-by-sex interaction and study-level random intercepts (6). The latter accounts for differences in
overall health of the populations across studies but assumes constant subgroup treatment effects. We have
also considered models with study-specific random treatment effects (𝛽k1,j ∼ N(0, 𝜎𝛽1)) but focused our
results presentation on the simpler models noting that models with more complex covariance structures
led to similar results. The small number of studies and large number of outcomes made the parameters
of the random effects variance–covariance matrix difficult to identify. To help improve convergence, we
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Table III. Percent bias, rMSE and joint CI coverage for the estimated treatment effect on con-
tinuous (𝛽1,1) and binary (𝛽2,1) outcomes whenmissingness depends on observed covariates only
(sporadically missing outcomes).
Bias (%) rMSE
Joint CI
Correlation (rho) %Missing Method 𝛽1,1 𝛽2,1 𝛽1,1 𝛽2,1 Coverage
20 Studies
Low (0.2) 20 Full data 0.0 0.9 0.040 0.076 0.952
Complete-cases 7.1 23.1 0.086 0.100 0.747
Fully Conditional 1 0.1 2.0 0.043 0.083 0.954
Fully Conditional 2 0.1 1.4 0.042 0.082 0.955
Joint model 0.0 1.3 0.037 0.080 0.949
50 Full data 0.1 1.1 0.040 0.076 0.952
Complete-cases 9.9 35.2 0.121 0.127 0.695
Fully Conditional 1 0.2 3.9 0.051 0.102 0.959
Fully Conditional 2 0.3 3.6 0.050 0.099 0.957
Joint model 0.1 2.9 0.037 0.080 0.949
High (0.7) 20 Full data 0.1 1.0 0.040 0.075 0.958
Complete-cases 7.3 23.3 0.085 0.093 0.582
Fully conditional 1 0.1 4.5 0.042 0.082 0.962
Fully conditional 2 0.1 3.7 0.042 0.080 0.956
Joint model 0.0 2.6 0.038 0.080 0.960
50 Full data 0.0 1.2 0.040 0.075 0.958
Complete-cases 10.1 34.9 0.121 0.128 0.503
Fully Conditional 1 0.1 7.3 0.052 0.101 0.945
Fully Conditional 2 0.1 5.9 0.048 0.099 0.946
Joint model 0.0 3.9 0.040 0.093 0.957
Five studies
Low (0.2) 20 Full data 0.2 1.8 0.042 0.079 0.949
Complete-cases 6.5 30.3 0.082 0.097 0.751
Fully Conditional 1 0.3 7.4 0.047 0.085 0.950
Fully Conditional 2 0.3 7.2 0.046 0.085 0.948
Joint model 0.1 2.3 0.040 0.083 0.954
50 Full data 0.2 1.6 0.042 0.079 0.949
Complete-cases 9.8 30.4 0.123 0.131 0.731
Fully Conditional 1 0.3 7.8 0.052 0.104 0.944
Fully Conditional 2 0.2 6.5 0.051 0.100 0.941
Joint model 0.1 2.4 0.043 0.094 0.946
High (0.7) 20 Full data 0.3 1.9 0.042 0.079 0.961
Complete-cases 6.4 31.1 0.081 0.097 0.600
Fully Conditional 1 0.4 12.4 0.045 0.085 0.941
Fully Conditional 2 0.3 7.6 0.043 0.085 0.947
Joint model 0.2 3.2 0.040 0.084 0.950
50 Full data 0.3 1.8 0.042 0.079 0.961
Complete-cases 9.7 41.2 0.121 0.133 0.532
Fully Conditional 1 0.4 16.6 0.053 0.106 0.939
Fully Conditional 2 0.3 8.3 0.050 0.101 0.942
Joint model 0.2 2.4 0.042 0.096 0.951
Study-level correlation is fixed across these scenarios: 𝜙 = 0.1. Fully Conditional 1: imputation includes
covariates only; Fully Conditional 2: imputation uses covariates and the other outcome.
rMSE, root mean squared error; CI, confidence interval.
fixed the level-2 covariances (off-diagonal parameters) to zero across the different models. Level-2 vari-
ance estimates were still imprecise, but convergence for these variances and level-1 variance/covariance
parameters was good (Gelman–Rubin factors smaller than 1.1).
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Figure 1. Joint confidence interval coverage of treatment effects on both outcomeswhen the probability of observ-
ing one outcome depends on both the observed covariates and the other outcome (sporadically missing data).
Study-level correlation is fixed across these scenarios: 𝜙 = 0.1. The lines are used to improve visualisation but
do not reflect an increase of a single parameter in the x-axis. FCS, fully conditional specification; CCA, complete
case analysis.
Figure 2. Percent bias of treatment effects on both outcomes when the probability of observing one outcome
depends on both the observed covariates and the other outcome (sporadically missing outcomes). Study-level
correlation is fixed across these scenarios: 𝜙 = 0.1. The lines are used to improve visualisation but do not reflect
an increase of a single parameter in the x-axis. FCS, fully conditional specification; CCA, complete case analysis.
We assumed that the outcomes followed a multivariate normal distribution, using latent normal vari-
ables for the two binary outcomes as described in Model (6). We assessed the statistical significance of
the sex-specific treatment effects by estimating simultaneous confidence/credible intervals and noting
whether they excluded the null value. In the joint hierarchical model, the joint credible intervals were
formed from the empirical posterior distribution; in the FCS–MI and CCA approaches, we used simul-
taneous confidence regions. Predictors of the missing data included all the variables in the substantive
model (treatment, female and the interaction between them) plus other relevant predictors like baseline
NYHA class and age.
Zdeath,ij ∼ N(𝜇1,ij, 1) P(deathij = 1) = P(Zdeath,ij > 0)
Znyha,ij ∼ N(𝜇2,ij, 1) P(nyhaij = 1) = P(Znyha,ij > 0)
walkij ∼ N
(
𝜇3,ij, 𝜎
2
walk
)
qolij ∼ N
(
𝜇4,ij, 𝜎
2
qol
) (6)
𝜇k,ij = 𝛽k,0 + 𝛽k,1CRT-Dij + 𝛽k,2femaleij + 𝛽k,3
(
CRT-Dij × femaleij
)
+ uk,ij + ek,ij
ek,ij ∼ N(0,𝛀e)uk,j ∼ N(0,𝛀u)
© 2016 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd. Statist. Med. 2016, 35 3676–3689
3685
M. GOMES, L. HATFIELD, AND S.-L. NORMAND
Figure 3. Subgroup treatment effects by gender on each outcome according to complete case analysis, fully
conditional specification and joint model for addressing the missing data. All subgroup treatment effects favour
CRT-D, except men on 6-min walk.
Figure 3 displays sex-specific treatment effects for each outcome, according to method for address-
ing the missing data. Overall, compared with ICD alone, CRT-D improved survival, quality-of-life and
NYHA class. Women benefited substantially more from treatment on the 6-min walk distance than men
and also showed more pronounced survival benefits, although this difference (𝛽k,3) was not statistically
significant on any outcome, based on simultaneous intervals with 95% coverage. However, the individ-
ual intervals for the treatment effect interaction estimate did indicate statistically significant differences
between men and women for mortality and 6-min walk (Supporting Information, Figure 3). Men and
women showed similar responses to treatment on quality-of-life and the NYHA improvement.
Complete-case analysis produced a smaller difference between men and women on survival and a
larger difference on 6-min walk compared with the other methods. The joint model and fully conditional
approaches led to similar point estimates of the differential treatment effect by sex, but the former reported
somewhat smaller intervals. We note that the probability of each outcome being observed was weakly
associated with the values of the other outcomes, so this application resembles the simulation scenarios
where the joint model and FCS performed similarly. When we allowed a heterogeneous treatment effect
across studies, the subgroup treatment effects and associated uncertainty remained fairly similar. With
only five trials, the between-study variance components were difficult to differentiate from zero.
7. Discussion
This paper compares two approaches for handling missing outcomes when combining individual patient
data across studies.We found that the fully conditional approach comparedwell with the joint hierarchical
model across most simulated scenarios and in the case study. The joint model had a small advantage in
the mean squared error and CI coverage, particularly when the outcomes were strongly correlated and a
large proportion of data was missing.
In a recent paper, He and Belin [19] compared a joint model and a fully conditional approach for
dealing with (non-hierachical) missing binary and continuous outcomes. The study shows that the two
approaches perform similarly (irrespective of the order in which the variables were imputed under the
FCS approach), although the joint model provided slightly better coverage in settings with smaller sam-
ples (N = 100). Our study extended these comparisons with a hierarchical setting (IPD meta-analysis).
Here, we might worry that the sequence of fully conditional models may not fully accommodate the
correlation structure across outcomes.We found that when outcomes are strongly correlated and the prob-
ability of one outcome depends on the other outcome, the joint hierarchical model provides CI coverage
consistently closer to nominal levels when compared with FCS–MI for estimating treatment effects. In
addition, we consider a missing data pattern unique to hierarchical settings – outcomes may be com-
pletely missing for level-2 units (in our example, the study). With systematically missing outcomes, we
also found that the joint model slightly outperformed the fully conditional approach, even with small
between-study heterogeneity (e.g. intra-cluster correlation of 0.1 and constant treatment effects).
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In this paper we use a standard implementation of MI using chained equations previously considered
for addressing missing predictors in IPD meta-analysis [1]. We believe that the current limitations of the
FCS-MI approach are mostly practical, and some improvements may be possible. For example, Carpenter
and Kenward [14, p. 221-2], suggest that, under an exchangeable correlation matrix (as assumed in our
study), the univariate imputation model for each continuous outcome should include both mean and
individual observations of the other outcomes (in this paper we have included only the latter). However,
those results may not generalise to discrete outcomes. In addition, with a non-exchangeable correlation
matrix (e.g. different correlations between outcomes across studies), the conditional parameters may give
information about the marginal covariance, threatening the validity of the fully conditional sampler [18].
Another potential extension would be to consider a probit model (instead of logistic model) to impute
the binary outcomes. While in theory this might improve the convergence of the FCS algorithm to the
posterior distribution implied by the joint hierarchical model, it is unclear the extent to which this would
improve the performance of the FCS approach. For example, Carpenter and Kenward [14, p. 95] high-
lighted that although strictly uncongenial, in practice, we can impute a binary variable using a logit model
and fit a probit model in the analysis, and vice versa.
While this study considered full-Bayesian analysis for estimating the joint hierarchical model, this
could be used with MI. An important feature of MI is that it allows the imputation model to be estimated
separately from the analysis model, providing further flexibility when compared with full-Bayesian anal-
ysis. First, there may be settings where we wish to include variables that are predictive of the missing
values and the outcomes but are beyond those included in the model for the complete data. For example,
post-randomisation variables often provide important information about the missingness but should not
be included in the analysis model [29]. Second, combining data from very few studies, say less than five,
causes computational problems for the joint hierarchical modelling. In these circumstances, a general
recommendation is to use MI in a two-stage IPD meta-analysis [2]. This would involve fitting a sepa-
rate model to each study, and then combining the estimated parameters of interest using inverse-variance
weightedmeta-analysis. Under this approach, the imputationmodel would have to be implementedwithin
study, and Rubin’s rules would have to be applied to the multiple imputed estimates in each study, before
undertaking the meta-analysis [2]. Third, while previous studies [13,16,30] found that approaches based
on multivariate normality performed relatively well when missing outcomes are not normally distributed,
there may be some cases where drawing from a posterior joint normal distribution may not be plausible,
for example, if continuous outcomes are extremely skewed or semi-continuous, such as hospital length
of stay. With MI, before imputing the data, we can use a suitable (e.g. box-cox) transformation to help
make the normality assumptionmore plausible. The transformed outcomes are thenmultiply imputed and
back-transformed onto the original scale before applying the analysis model [15]. With semi-continuous
outcomes, a two-step imputation procedure may be preferred [31].
This study has some limitations. This paper considers missing outcomes only as the focus is on the
relative merits of joint modelling and FCS when dealing with multiple incomplete outcomes. Obvi-
ously, one could have both outcomes and predictors missing for some of the studies. With several
incomplete outcomes and predictors, full-Bayesian modelling becomes increasingly challenging [16].
For this reason, previous work addressing missing predictors in IPD meta-analysis have advocated MI
approaches [1, 2].
When designing a simulation study, the data generating process should avoid favouring any of the
methods under comparison. Our simulation design may favour the joint hierarchical model because: (a)
the outcomes are drawn from a joint distribution (using copulas) and (b) the covariance structure are
explicitly partitioned into individual and study-level components. We have considered an alternative data
generating process (Supporting Information, Appendix D), which is more in line with the FCS approach.
With the new simulation design, the performance of the FCS approach slightly improves (better CI cov-
erage and reduced rMSE). However, the joint hierarchical model still provides consistently the lowest
rMSE and coverage closest to nominal levels across the scenarios considered (Supporting Information,
Tables 3 and 4).
The methods considered in this paper are not readily applicable to IPD meta-analysis of longitudinal
data. For example, imputing survival outcomes are not currently supported by multilevel MI using
chained equations, although in principle this could be achieved by imputing under a Cox hierarchical
regression model. While survival times could be jointly modelled with incomplete missing longitudinal
outcomes [32], this would be complicated by data being clustered within studies.
Throughout the paper, we have assumed that the probability of observing one outcome was indepen-
dent of its underlying unobserved values, conditional on the observed data (MAR). In practice, the true
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missingness mechanism is unknown given the data at hand. An assessment of the relative merits of the
alternative approaches in addressing potential missing not at random mechanisms is underway. In this
context, the use of selection models within a full-Bayesian framework is appealing, in particular, when
external information on the reasons for the missing data is available (e.g. expert opinion) to inform the
sensitivity parameters via the priors [33]. In general, we believe that accurately reflecting the correlation
structure strengthens methods for handling incomplete correlated mixed outcomes in IPD meta-analysis.
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